These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22252020)

  • 1. The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus.
    Lemkes BA; Bähler L; Kamphuisen PW; Stroobants AK; Van Den Dool EJ; Hoekstra JB; Nieuwland R; Gerdes VE; Holleman F
    J Thromb Haemost; 2012 Apr; 10(4):639-46. PubMed ID: 22252020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes.
    Kapłon-Cieślicka A; Rosiak M; Postuła M; Serafin A; Kondracka A; Opolski G; Filipiak KJ
    Kardiol Pol; 2013; 71(9):893-902. PubMed ID: 24065375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity.
    Lee S; Eichelberger B; Kopp CW; Panzer S; Gremmel T
    Vascul Pharmacol; 2021 Feb; 136():106819. PubMed ID: 33207279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin.
    Lattanzio S; Santilli F; Liani R; Vazzana N; Ueland T; Di Fulvio P; Formoso G; Consoli A; Aukrust P; Davì G
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications.
    Spectre G; Arnetz L; Östenson CG; Brismar K; Li N; Hjemdahl P
    Thromb Haemost; 2011 Sep; 106(3):491-9. PubMed ID: 21800009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients.
    Ohmori T; Yatomi Y; Nonaka T; Kobayashi Y; Madoiwa S; Mimuro J; Ozaki Y; Sakata Y
    J Thromb Haemost; 2006 Jun; 4(6):1271-8. PubMed ID: 16706971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease.
    Grove EL; Hvas AM; Mortensen SB; Larsen SB; Kristensen SD
    J Thromb Haemost; 2011 Jan; 9(1):185-91. PubMed ID: 20955349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
    Capodanno D; Patel A; Dharmashankar K; Ferreiro JL; Ueno M; Kodali M; Tomasello SD; Capranzano P; Seecheran N; Darlington A; Tello-Montoliu A; Desai B; Bass TA; Angiolillo DJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):180-7. PubMed ID: 21386092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of the anti-platelet effects of aspirin and clopidogrel.
    Li C; Hirsh J; Xie C; Johnston MA; Eikelboom JW
    J Thromb Haemost; 2012 Apr; 10(4):521-8. PubMed ID: 22268852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin.
    Neergaard-Petersen S; Hvas AM; Grove EL; Larsen SB; Gregersen S; Kristensen SD
    PLoS One; 2015; 10(7):e0132629. PubMed ID: 26148094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and Platelet Response to Low-Dose Aspirin.
    Al-Sofiani ME; Yanek LR; Faraday N; Kral BG; Mathias R; Becker LC; Becker DM; Vaidya D; Kalyani RR
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4599-4608. PubMed ID: 30265320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between urinary 11-dehydrothromboxane B2 detection and platelet Light Transmission Aggregometry (LTA) assays for evaluating aspirin response in elderly patients with coronary artery disease.
    Liu T; Zhang J; Chen X; Feng X; Fu SW; McCaffrey TA; Liu M
    Gene; 2015 Oct; 571(1):23-7. PubMed ID: 26095809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin withdrawal in patients treated with ticagrelor presenting with non-ST elevation myocardial infarction.
    Beigel R; Mazin I; Koifman E; Shechter M; Pres H; Shlomo N; Rosenberg N; Asher E; Matetzky S
    J Thromb Haemost; 2018 Apr; 16(4):663-669. PubMed ID: 29443445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control.
    Parker WAE; Sagar R; Kurdee Z; Hawkins F; Naseem KM; Grant PJ; Storey RF; Ajjan RA
    Cardiovasc Diabetol; 2021 Dec; 20(1):238. PubMed ID: 34920734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease.
    Henry P; Vermillet A; Boval B; Guyetand C; Petroni T; Dillinger JG; Sideris G; Bal dit Sollier C; Drouet L
    Thromb Haemost; 2011 Feb; 105(2):336-44. PubMed ID: 21136023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    Platelets; 2011; 22(3):188-95. PubMed ID: 21231857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal inhibition of platelet cyclooxygenase-1 by aspirin in metabolic syndrome.
    Smith JP; Haddad EV; Taylor MB; Oram D; Blakemore D; Chen Q; Boutaud O; Oates JA
    Hypertension; 2012 Mar; 59(3):719-25. PubMed ID: 22311905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets.
    Würtz M; Grove EL; Wulff LN; Kaltoft AK; Tilsted HH; Jensen LO; Hvas AM; Kristensen SD
    JACC Cardiovasc Interv; 2010 Aug; 3(8):828-35. PubMed ID: 20723855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of aspirin response by Multiplate whole blood aggregometry and light transmission aggregometry.
    Pedersen SB; Grove EL; Nielsen HL; Mortensen J; Kristensen SD; Hvas AM
    Platelets; 2009 Sep; 20(6):415-20. PubMed ID: 19658002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.